Literature DB >> 18063854

Interplay between dose and frequency of GnRH administration in determining pituitary gonadotropin responsiveness.

Virginia A Hughes1, Paul A Boepple, William F Crowley, Stephanie B Seminara.   

Abstract

BACKGROUND/AIMS: The dose, frequency and contour of GnRH stimulation of the pituitary gonadotrope have been shown to be independent variables influencing pituitary LH secretion. The dynamic interaction between these variables during physiological and pathophysiological states has yet to be examined.
METHODS: Twelve men with GnRH deficiency and idiopathic hypogonadotropic hypogonadism undergoing GnRH therapy participated in a series of studies in which 2 log orders of GnRH doses (2.5-250 ng/kg) were administered at frequencies varying from 0.5 to 8 hourly. Pituitary responses were characterized by pulse amplitudes and nadirs. The relative sensitivity of the gonadotrope to GnRH was defined as that dose of GnRH capable of eliciting an LH pulse amplitude equal to the mean LH amplitude in normal men.
RESULTS: As GnRH stimulation of the gonadotrope slowed from 0.5 to 8 hourly, pulse amplitudes of LH increased whereas mean nadirs decreased (p < 0.05). Unique, curvilinear dose-response curves were found for each frequency that demonstrated an increasing slope (p < 0.03) as the frequency of GnRH stimulation slowed. Thus, the relative sensitivity of the gonadotrope increased as the frequency of GnRH stimulation decreased over the range of physiological frequencies tested.
CONCLUSIONS: We conclude that a delicate interplay exists between the dose and frequency of GnRH stimulation of the gonadotrope that determines pituitary LH gonadotropin responsiveness in the human. Slower frequencies favor increased LH release largely due to decreasing LH nadirs and improved sensitivity of the gonadotropes to GnRH stimulation. (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18063854     DOI: 10.1159/000112421

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  5 in total

Review 1.  GnRH signaling, the gonadotrope and endocrine control of fertility.

Authors:  Stuart P Bliss; Amy M Navratil; Jianjun Xie; Mark S Roberson
Journal:  Front Neuroendocrinol       Date:  2010-05-06       Impact factor: 8.606

2.  Congenital idiopathic hypogonadotropic hypogonadism: evidence of defects in the hypothalamus, pituitary, and testes.

Authors:  Gerasimos P Sykiotis; Xuan-Huong Hoang; Magdalena Avbelj; Frances J Hayes; Apisadaporn Thambundit; Andrew Dwyer; Margaret Au; Lacey Plummer; William F Crowley; Nelly Pitteloud
Journal:  J Clin Endocrinol Metab       Date:  2010-04-09       Impact factor: 5.958

Review 3.  GnRH pulsatility, the pituitary response and reproductive dysfunction.

Authors:  Rie Tsutsumi; Nicholas J G Webster
Journal:  Endocr J       Date:  2009-07-17       Impact factor: 2.349

4.  Predictive factors for pituitary response to pulsatile GnRH therapy in patients with congenital hypogonadotropic hypogonadism.

Authors:  Jiang-Feng Mao; Xi Wang; Jun-Jie Zheng; Zhao-Xiang Liu; Hong-Li Xu; Bing-Kun Huang; Min Nie; Xue-Yan Wu
Journal:  Asian J Androl       Date:  2018 Jul-Aug       Impact factor: 3.285

5.  Efficacy and safety of pulsatile gonadotropin-releasing hormone therapy in patients with congenital hypogonadotropic hypogonadism: a multicentre clinical study.

Authors:  Ming Hao; Jiang-Feng Mao; Qing-Bo Guan; Long Tian; Hu Han; Hong-En Lei; Dong-Mei Zheng; Zhen-Hua Tian; Min Nie; Xi Wang; Bing-Qing Yu; Yin-Jie Gao; Xue-Yan Wu
Journal:  Ann Transl Med       Date:  2021-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.